31 – 40 of 115
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2022
 - 
                        Mark
        2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
    
    
- Contribution to journal › Scientific review
 
 - 
                        Mark
        Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029 : A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy
    
    
- Contribution to journal › Letter
 
 - 
                        Mark
        European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
    
    
- Contribution to journal › Scientific review
 
 - 
                        Mark
        Microdissection Testicular Sperm Extraction Versus Multiple Needle-pass Percutaneous Testicular Sperm Aspiration in Men with Nonobstructive Azoospermia : A Randomized Clinical Trial
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Re : Performance of a Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–derived Risk-stratification Tool for High-risk and Very High-risk Prostate Cancer
    
    
- Contribution to journal › Debate/Note/Editorial
 
 - 
                        Mark
        A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re : Sylvia H.J. Jochems, Josef Fritz, Christel Häggström, Bengt Järvholm, Pär Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers: Smoking Cessation Remains a Cornerstone in Preventive Health Care Overall and for Men with Prostate Cancer
    
    
- Contribution to journal › Letter
 
 - 
                        Mark
        Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
    
    
- Contribution to journal › Article
 
 - 2021
 - 
                        Mark
        When the Molecular Subtype Is Hidden Behind a Veil of Stroma
    
    
- Contribution to journal › Debate/Note/Editorial
 
 
